Latest Breaking News On - Annuak meeting - Page 1 : comparemela.com

An innovative study of short-course nivolumab plus ipilimumab prior to resection of MMR-deficient colon cancer has achieved unprecedented pathologic responses, with no recurrences.

France generalUnited kingdomCity ofNoord hollandJames larkinMyriam chalabiNetherlands cancer instituteEuropean society for medical oncologyUniversity of valenciaEuropean societyMedical oncologyAnnuak meetingNew resultsRoyal marsdenColorectal cancerAlignant neoplasia